WHO Target Product Profiles for Rift Valley Fever Virus Vaccines

Overview

This TPP Guideline is meant for private and public parties that are professionally involved in the development and eventual production of a vaccine against RVF and to facilitate the most expeditious development of vaccine candidates against RVF.

This TPP guideline should be used and interpreted applying necessary awareness of its limitations, since much is still unknown about RVF virus life cycle, pathology and the role of the various arms of the adaptive immune response in protective immunity.